InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Rouan Sarah Kathryn, Director. Officer active across 2 companies, notably Navidea Biopharmaceuticals, INC.. Cumulatively, 7 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €55k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Rouan Sarah Kathryn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,150 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-003108:0
1,240 shares@ US$24.14745.2% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-25-052255:0
Canonical exit: 29 Jun 2025 (T+90)
1,240 shares@ US$24.14745.2% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-25-049717:0
Canonical exit: 29 Jun 2025 (T+90)
11,000 shares@ US$4.889.4% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-117514:0
25,000 shares@ US$8.3236.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-003008:0
30,000 shares@ US$8.3243.5% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-001973:0
4,892 shares0Common StockSEC:0001437749-21-016598:0
7 of 7 declarations
About Rouan Sarah Kathryn
Sarah Kathryn Rouan is a Board Member at Navidea Biopharmaceuticals, Inc. She contributes to the governance of the company by bringing her expertise to the board. Her role involves overseeing operations and ensuring compliance with regulations. With her experience, she plays a vital role in strategic decision-making.
